Reginald L. Hardy - 17 May 2022 Form 4 Insider Report for Brickell Biotech, Inc.

Role
CHAIRMAN OF THE BOARD, Director
Signature
/s/ Christine G. Long, Attorney-in-Fact for Reginald L. Hardy (power of attorney previously filed)
Issuer symbol
N/A
Transactions as of
17 May 2022
Net transactions value
$0
Form type
4
Filing time
17 May 2022, 17:18:21 UTC
Previous filing
25 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FRTX Stock Option (right to buy) Award $0 +65,000 $0.000000 65,000 17 May 2022 Common Stock 65,000 $0.1875 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.